Drug General Information (ID: DDIVKL6Q9F)
  Drug Name Papaverine Drug Info Nefazodone Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Vasodilator Agents Antidepressants
  Structure

 Mechanism of Papaverine-Nefazodone Interaction (Severity Level: Moderate)
     Additive hypotensive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Papaverine Nefazodone
      Mechanism Hypotensive effects
Phosphodiesterase 4D/5A  Inhibitor
Potentiate the hypotensive effect of antihypertensive agents
      Key Mechanism Factor 1
Factor Name Phosphodiesterase Structure Sequence
Protein Family Cyclic nucleotide phosphodiesterase family
Protein Function
Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes.
    Click to Show/Hide
      Mechanism Description
  • Additive hypotensive effects by the combination of Papaverine and Nefazodone 

Recommended Action
      Management Caution and close monitoring for altered efficacy and safety are recommended if patients receive nefazodone with agents that can produce significant hypotension such as antihypertensive agents or vasodilators. Patients should be made aware of the possible side effects (e.g., dizziness, lightheadedness, orthostasis) and be cautioned about driving, operating machinery, or performing other hazardous tasks.

References
1 Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
2 Product Information. Serzone (nefazodone). Bristol-Myers Squibb, Princeton, NJ.
3 Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]